Ocugen, INC. (OCGN) SEC Filings — 2024
34 SEC filings for Ocugen, INC. (OCGN) in 2024.
Filings
- Ocugen Files 8-K for Other Events and Exhibits — 8-K · Dec 3, 2024
- Ocugen Board Shakeup & Officer Compensation Disclosed — 8-K · Nov 15, 2024
- Ocugen Q3 Revenue Surges to $1.01M, R&D Costs Decline — 10-Q · Nov 14, 2024
- Ocugen Files 8-K: Regulation FD & Exhibits — 8-K · Nov 12, 2024
- Ocugen, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Ocugen, INC. SC 13G Filing — SC 13G · Nov 8, 2024
- Ocugen Files 8-K: Material Agreement, Financial Obligation, Equity Sale — 8-K · Nov 8, 2024
- Ocugen Files 8-K on Operations and Financials — 8-K · Nov 8, 2024
- Ocugen, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Ocugen, INC. SC 13G Filing — SC 13G · Oct 22, 2024
- Ocugen, INC. SC 13G Filing — SC 13G · Oct 16, 2024
- Ocugen, Inc. Files 8-K Report — 8-K · Aug 13, 2024
- Ocugen Files 10-Q for Q2 2024 — 10-Q · Aug 8, 2024
- Ocugen Files 8-K: Routine Update — 8-K · Aug 5, 2024
- Ocugen, Inc. Files 8-K with Material Agreements — 8-K · Aug 1, 2024
- Ocugen Appoints New Auditor, Dismisses PricewaterhouseCoopers — 8-K · Jul 8, 2024
- Ocugen Files 8-K on Security Holder Vote — 8-K · Jun 28, 2024
- Ocugen Files Proxy Statement Supplement — DEFA14A · Jun 18, 2024
- Ocugen Acquires Innovimmune Biotherapeutics for $15M — 8-K · Jun 6, 2024
- Ocugen Files Definitive Proxy Statement for 2024 Shareholder Meeting — DEF 14A · May 28, 2024
- Ocugen, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Ocugen Files 8-K: Rights, Bylaws, and Financials Updated — 8-K · May 10, 2024
- Ocugen, Inc. Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
- Ocugen, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
- Ocugen to Acquire Liminal BioSciences for $10M — 8-K · Apr 8, 2024
- Ocugen Files 8-K for Operations and Financials — 8-K · Apr 2, 2024
- Ocugen Restates Financials Due to Internal Control Review — 8-K · Apr 1, 2024
- Ocugen to Acquire Innovimmune for up to $150M — 8-K · Mar 21, 2024
- Ocugen Files 8-K: Corporate Changes and Financial Updates — 8-K · Mar 20, 2024
- Ocugen Files 8-K Report — 8-K · Mar 18, 2024
- Ocugen Files 8-K on Feb 21, 2024, for Regulation FD Disclosure — 8-K · Feb 21, 2024
- Ocugen, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- State Street Corp. Updates Passive Stake in Ocugen Inc. — SC 13G/A · Jan 22, 2024
- Ocugen 8-K: Officer/Director Changes, Compensation & Exhibits — 8-K · Jan 8, 2024